Every carbon nucleophile so far has needed an electrophilic partner that could be attacked — a carbonyl, or an alkyl halide willing to do SN2. That leaves out the two partners organic chemists most often want to join: an aryl halide and another aryl group. Aryl halides do not do SN2 at all, and aryl Grignards are too indiscriminate to be pointed at one site in a complicated molecule.
Cross-coupling solves this with a transition metal — almost always palladium — that takes the two pieces in one at a time, holds both, and then pushes them together. The 2010 Nobel Prize in Chemistry went to Heck, Negishi and Suzuki for it, and it is now the most-used carbon–carbon bond-forming reaction in the pharmaceutical industry.
One catalytic cycle, three steps
The reactions below differ in what the nucleophilic partner is, but the palladium does the same three things every time. Learn the cycle once and the named reactions stop needing to be memorized separately.
| Step | What happens | Palladium goes |
|---|---|---|
| Oxidative addition | Pd inserts into the Ar–X bond, ending up bonded to both pieces | Pd(0) → Pd(II) |
| Transmetalation | The R group moves from its own metal onto the palladium | stays Pd(II) |
| Reductive elimination | The two organic groups on Pd join and leave as Ar–R | Pd(II) → Pd(0) |
The names describe the palladium's oxidation state, which is the easiest way to keep them straight. Oxidative addition oxidizes the metal by two; reductive elimination reduces it by two and hands back the Pd(0) the cycle started with. That is why palladium is a catalyst rather than a reagent: it ends each turn exactly as it began, and a few mole percent turns over thousands of times.
The named reactions, by what the partner is
| Reaction | Nucleophilic partner | Forms |
|---|---|---|
| Suzuki | Boronic acid, R–B(OH)2, with base | Biaryls, most often |
| Stille | Organostannane, R–SnBu3 | The same, with no base needed |
| Negishi | Organozinc, R–ZnX | The same, and tolerates esters |
| Sonogashira | Terminal alkyne, with a copper cocatalyst | An aryl alkyne |
| Heck | An alkene — no organometallic at all | A substituted alkene |
The Suzuki coupling is the one to know properly. Boronic acids are air-stable, water-tolerant, low in toxicity and easy to store, which is why it displaced the alternatives industrially even though the Stille coupling works at least as well chemically — organotin reagents are seriously toxic. The base is not optional: it converts the boronic acid to a borate, which is what transfers the R group in the transmetalation step.
The Heck reaction is the odd one out and worth separating. There is no organometallic nucleophile, so there is no transmetalation. The alkene inserts into the Ar–Pd bond instead, and a β-hydride elimination releases the product. It usually gives the trans alkene, and the new bond forms at the less substituted carbon.
Why this changed how molecules get made
Cross-coupling is convergent. Two halves are built separately and joined near the end, instead of one chain being extended step by step. Since yields multiply, joining two five-step pieces at the end beats a linear ten-step route badly — and both halves can be varied independently, which is exactly what a medicinal chemistry program needs when it wants fifty analogs of one scaffold.
What carries forward
A palladium catalyst joins an aryl or vinyl halide to a carbon partner by oxidative addition, transmetalation and reductive elimination, and the named reactions differ only in what the partner is. Suzuki with a boronic acid is the default; Heck is the one with no organometallic and a β-hydride elimination at the end. Retrosynthetically, a biaryl bond is now a disconnection you should see immediately.